CoCensys

Irvine, United States Founded: 1989 • Age: 37 yrs Acquired By Purdue Pharma
Small molecule therapeutics for CNS disorders were developed.

About CoCensys

CoCensys is a company based in Irvine (United States) founded in 1989 was acquired by Purdue Pharma in August 1999.. CoCensys operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.

  • Headquarter Irvine, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $750 K (USD), Grant

    Jun 03, 1999

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Purdue Pharma

    (Aug 06, 1999)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of CoCensys

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $750,000
  • First Round

    (16 Oct 1997)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 1999 Amount Grant - CoCensys Valuation

investors

Apr, 1999 Amount Grant - CoCensys Valuation

investors

Jun, 1998 Amount Post-IPO - CoCensys Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CoCensys

CoCensys has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Purdue Pharma and National Institute of Neurological Disorders and Stroke. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Research on neurological disorders and stroke is conducted and funded.
Founded Year Domain Location
Pain-relief drugs are developed by the private pharmaceutical company.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CoCensys

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CoCensys

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cocensys Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CoCensys

CoCensys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Drugs for CNS disorders are developed and advanced.
domain founded_year HQ Location
Developer of therapeutic solutions for the treatment of diabetes
domain founded_year HQ Location
Genetically engineered cell therapies are developed for multiple disorders.
domain founded_year HQ Location
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
domain founded_year HQ Location
Therapies for neurological and neuropsychiatric diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cocensys

Frequently Asked Questions about CoCensys

When was CoCensys founded?

CoCensys was founded in 1989 and raised its 1st funding round 8 years after it was founded.

Where is CoCensys located?

CoCensys is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

What does CoCensys do?

CoCensys was founded in 1989 in Irvine, United States, and focused on the biotechnology sector for central nervous system disorders. Small molecule therapeutics were developed, including an epalon analog co-developed with Wyeth for anxiety treatment. NMDA receptor antagonists for neuropsychiatric conditions were pursued in partnership with Parke-Davis, and ophthalmic candidates were advanced with Senju Pharma. The company was acquired by Purdue Pharma in 1999 for an undisclosed amount.

Who are the top competitors of CoCensys?

CoCensys's top competitors include Jazz Pharmaceuticals, Neurocrine and Biohaven Pharmaceutical.

Who are CoCensys's investors?

CoCensys has 2 investors. Key investors include Purdue Pharma, and National Institute of Neurological Disorders and Stroke.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available